Description

TA-1 – 5 mg

(Thymosin Alpha-1 – Immunomodulatory Peptide)

Thymosin Alpha-1 (TA-1) is a synthetic 28-amino acid peptide originally isolated from thymic tissue and studied for its potent immunomodulatory and cytoprotective properties. It plays a critical role in the regulation of innate and adaptive immunity, influencing T-cell differentiation, cytokine signaling, and immune system resilience in preclinical models.

TA-1 has been extensively evaluated in research involving immune regulation, infection control, and cellular defense, making it a key compound for studies focused on immune restoration and anti-inflammatory pathways.

---

Mechanism of Action (Based on Preclinical and Clinical Research):

• T-cell modulation: Promotes differentiation and activation of T lymphocytes, enhancing immune response balance.

• Cytokine regulation: Modulates expression of IL-2, IFN-γ, and other immune mediators in experimental models.

• Innate immunity activation: Stimulates dendritic cells and natural killer (NK) cell activity.

• Cellular protection: Exhibits anti-inflammatory and antioxidant activity through regulation of NF-κB and redox signaling.

• Host defense support: Studied for its role in enhancing resistance to immune and oxidative stress.

---

Potential Benefits (Based on Preclinical Research):

• Enhanced immune system modulation and resilience

• Improved cellular defense and stress response

• Support for balanced inflammatory signaling

• Studied in viral, autoimmune, and immunosenescence models

• Applications in immune health, regenerative, and anti-inflammatory research

---

For Research Use Only. Not for Human Consumption.
This compound is not approved by the FDA or any regulatory agency and is intended solely for laboratory research.